Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US Capitol Capsule: Cancer Therapies, Orphan Drugs Dominated 2015 Approvals; PCSK9s Arrived

This article was originally published in Scrip

Executive Summary

Cancer therapies dominated US drug approvals in 2015, with the FDA's Center for Drug Evaluation and Research (CDER) also giving its nod to a record number of medicines that had gained orphan drug designation.